Revised Haryana EML Total Drugs = 284 Total Components ... lists... · mg/ml for Spinal Anaesthesia...
Transcript of Revised Haryana EML Total Drugs = 284 Total Components ... lists... · mg/ml for Spinal Anaesthesia...
Sr. No. Medicines Dosage Forms Strength
GH CHC PHC/UD Sub centre OPD IPD OT RC LP
1 1 Halothane Inhalation
3% to 5% in
oxygen/Nitrous Oxide.
Maint 0.5-1%,(250ml)
GH OT RC
2 2 Ketamine Injection, (as hydrochloride) 50 mg /ml,10 ml vial GH CHC OT RC
3 3 Nitrous oxide Inhalation GH OT LP
4 4 Oxygen Inhalation (medicinal gas) GH CHC PHC Sub centre OT LP
5 5 Thiopentone Injection (sodium) Powder 0.5 g GH OT RC
6 6 Midazolam Injection 1 mg/ml GH CHC OT RC
7 7 Propofol Injection1% vial (10mg/ml ,10
ml vial)GH OT RC
8 8
*Isoflurane
*Purchase in small quantity &
prescription has to be
monitored
Inhalation 100 ml GH OT RC
9 9 Fentanyl Injection 25 mcg/ml(2ml) GH OT RC
Category Usage
1. ANAESTHETICS
1.1 General anesthetics and oxygen
Revised Haryana EML
Total Drugs = 284
Total Components = 428
* All the drugs to be dispensed in OPD will be made available in IPD as and when required.
* All drugs in OPD,IPD should be made available in OT as and when required.
* The column IPD combines the drugs to be made available at different work stations of the hospital like wards,injection room,Labour Room, emergency
department,ICU,SNCU,minor OT or any other.
Sr. No. Medicines Dosage Forms Strength
GH CHC PHC/UD Sub centre OPD IPD OT RC LP
Category Usage
10 10 Sevoflurane Inhalation 250 ml GH OT RC
11 11 Bupivacaine For epidural &
local anesthesia Injection (hydrochloride) 0.5% 5 ml ampoule GH CHC OT RC
12 12
Bupivacaine heavy 5 mg with
Dextrose Monohydrate 80
mg/ml for Spinal Anaesthesia
Injection5 mg + 80 mg/ml,4 ml
ampouleGH CHC OT RC
13 Jelly sterile 2%, 30 gm GH CHC PHC IPD RC
14 Jelly sterile 5% 20 gm GH CHC PHC IPD RC
15 Injection 2%, 30 ml vial GH CHC PHC Sub centre IPD RC
16 Injection ( Heavy) 2%, 2 ml vial GH CHC OT LP
17 Injection 4%, 30 ml vial GH OT LP
14 18 Lignocaine Hydrochloride +
AdrenalineInjection
2% + Adrenaline
1:80,000, 30 ml vialGH CHC PHC IPD RC
19 Injection (sulphate) 0.5 mg/ml, 1 ml
ampouleGH CHC PHC IPD OT RC
20 Injection (sulphate) 0.5 mg/ml, 20 ml
ampouleGH IPD OT RC
16 21 Glycopyrolate Injection0.2 mg/ml 1 ml
ampouleGH IPD RC
17 22 Diazepam Injection 5 mg/ml, 2 ml
ampoule GH CHC PHC IPD RC
23 Tablet (sodium) 50 mg GH CHC PHC Sub centre OPD RC
24 Injection25 mg/ml, 3 ml
AmpouleGH CHC PHC IPD RC
25 Gel 1% GH CHC PHC OPD RC
2.1 Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs)
18 Diclofenac
15 Atropine.
2. ANALGESICS, ANTIPYRETICS, NON-STEROIDAL ANTI-INFLAMMATORY MEDICINES (NSAIMs), MEDICINES USED TO TREAT GOUT AND DISEASE
MODIFYING AGENTS IN RHEUMATOID DISORDERS (DMARDs)
1.2 Local anaesthetics
13 Lignocaine Hydrochloride
1.3 Preoperative medication and sedation for short-term procedures
Sr. No. Medicines Dosage Forms Strength
GH CHC PHC/UD Sub centre OPD IPD OT RC LP
Category Usage
19 26Diclofenac Sodium 50 mg +
Paracetamol 325 mg TabTablet 50 mg + 325 mg GH CHC PHC OPD RC
27 Tablet 200 mg GH CHC PHC OPD RC
28 Tablet 400 mg GH CHC PHC OPD RC
21 29 Thiocolchicoside Tablet 4mg GH CHC OPD RC
30 Tablet 500 mg GH CHC PHC Sub centre OPD RC
31 Suspension 125 mg/5ml,60 ml GH CHC PHC Sub centre OPD RC
32 Injection150 mg/ml,2 ml
ampouleGH CHC PHC IPD RC
33 Drops 150 mg/ml GH CHC PHC OPD RC
23 34 Aceclofenac 100mg Tablet 100 mg GH CHC PHC OPD RC
35 Tablet 10 mg GH IPD RC
36 Injection10 mg/ml, 1ml
ampouleGH IPD RC
37 Tablet 50 mg GH CHC OPD RC
38 Injection50 mg/ml 2 ml
ampouleGH CHC IPD RC
26 39
*Pentazocine lactate
*Purchase in small quantity &
prescription has to be
monitored
Injection25 mg/ml, 1 ml
AmpouleGH CHC PHC IPD RC
27 40
*Pethidine Hydrochloride
*Purchase in small quantity &
prescription has to be
monitored
Injection50 mg/ml,1 ml
ampouleGH IPD RC
28 41 Allopurinol Tablet 100 mg GH CHC PHC OPD LP
29 42 Hydroxy Chloroquine Tablet (Sulfate) 200 mg GH CHC OPD RC
30 43 Sulfasalazine Tablet 500 mg GH OPD RC
31 44 Methotraxate Tablet 2.5 mg GH OPD RC
2.3 Medicines used to treat gout
2.4Disease modifying agents used in rheumatoid disorders (DMARDs)
2.2 Opioid analgesics
24
Morphine
Sulphate/Hydrochloride
*Purchase in small quantity &
prescription has to be
monitored
25 Tramadol Hydrochloride
20 Ibuprofen
22 Paracetamol
Sr. No. Medicines Dosage Forms Strength
GH CHC PHC/UD Sub centre OPD IPD OT RC LP
Category Usage
45 Tablet 10 mg GH CHC PHC OPD RC
46 Suspension 5 mg/ml,60 ml GH CHC PHC Sub centre OPD RC
47 Drops 10mg/ml GH OPD RC
33 48 Chlorpheniramine Tablet (hydrogen maleate) 4 mg GH CHC PHC Sub centre OPD RC
34 49 Pheniramine maleate Injection 22.75 mg/ml,2 ml GH CHC PHC Sub centre IPD RC
50 Tablet 10 mg GH CHC PHC OPD RC
51 Tablet 25 mg GH CHC PHC OPD RC
36 52 Dexamethasone Injection (disodium) 4 mg/ml,2 ml ampoule GH CHC PHC Sub centre IPD RC
37 53 HydrocortisonePowder for injection
(sodium succinate) 100 mg vial GH CHC PHC Sub centre IPD RC
54 Tablet 10 mg GH CHC PHC OPD RC
55 Tablet 20 mg GH CHC PHC OPD RC
56 Suspension 5mg/5ml, 60 ml GH OPD RC
39 57 Methyl Prednisolone Injection 1 gm vial GH IPD LP
40 58 Adrenaline Injection 1 mg/ml (1:1000) ( 1
ml ampoule) GH CHC PHC IPD LP
59 Tablet 250 mg GH IPD LP
60 Tablet 500 mg GH IPD LP
42 61 Antisnake venom(polyvalent
solution)Injection 10 ml vial GH CHC PHC IPD RC
43 62Antisnake venom (polyvalent
solution)(Dry Powder)Injection 10 ml vial GH CHC PHC IPD RC
44 63 Calcium gluconate Injection 100 mg/ml, 10 ml amp GH CHC IPD LP
45 64 Naloxone Injection (hydrochloride) 400 mcg,1ml ampoule GH IPD LP
46 65 Pralidoxime (PAM) Injection 1 gm vial GH CHC IPD LP
3. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS
4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONING
4.1 Non-specific
41 Charcoal activated
38 Prednisolone
There is no evidence for complete clinical similarity between prednisolone and dexamethasone at high doses
32 Cetrizine
35 Hydroxyzine
4.2 Specific
Sr. No. Medicines Dosage Forms Strength
GH CHC PHC/UD Sub centre OPD IPD OT RC LP
Category Usage
47 66 Disodium Edetate Injection150 mg/mL ,2ml
ampouleGH IPD LP
48 67 Penicillamine Capsule/Tablet 250 mg GH IPD LP
49 68 Deferiprone (Iron Chelator) Tablet/capsule 250 mg GH IPD LP
69 Tablet 100 mg, GH CHC PHC OPD RC
70 Tablet 200 mg GH CHC PHC OPD RC
71 Suspension 20 mg/ml GH CHC PHC OPD RC
72 Injection 2 mg/ml 2 ml ampoule GH CHC IPD RC
73 Tablet 1 mg GH CHC OPD RC
74 Tablet 2 mg GH CHC OPD RC
52 75
Magnesium sulphate For use
in eclampsia and severe pre-
eclampsia and not for other
convulsant disorders
Injection500mg/ml,1ml
ampouleGH CHC PHC Sub centre IPD RC
76 Tablet 30 mg GH CHC PHC OPD RC
77 Tablet 60 mg GH CHC PHC OPD RC
78 Suspension 20 mg/ 5 ml GH CHC PHC OPD RC
79 Injection 200 mg/ ml GH CHC PHC IPD RC
80 Tablet (sodium) 100 mg GH CHC PHC OPD RC
81 Suspension 100 mg/ 5 ml GH CHC PHC OPD RC
82 Injection (sodium) 50 mg/ml GH CHC PHC IPD RC
83Enteric coated tablet
(sodium) 200 mg GH CHC OPD RC
84Enteric coated tablet
(sodium) 500 mg GH OPD RC
85 Tablet 250 mg GH OPD RC
86 Tablet 500 mg GH OPD RC
57 87 Clobazam Tablet 10 mg GH OPD LP
51 Lorazepam
53 Phenobarbitone
4.2 Specific (Complementary)
5. ANTICONVULSANTS/ANTIEPILEPTICS
50 Carbamazepine
56Divaloprex Sodium equivalent
to Valproic Acid
54 Phenytoin
55 Sodium valproate/Valproic
acid
Sr. No. Medicines Dosage Forms Strength
GH CHC PHC/UD Sub centre OPD IPD OT RC LP
Category Usage
88 Chewable tablet 400 mg GH CHC PHC Sub centre OPD RC
89 Suspension 200 mg/5 ml GH CHC PHC Sub centre OPD RC
59 90 Ivermectin Tablet 6 mg GH OPD RC
91 Capsule (anhydrous) 250 mg, GH CHC PHC OPD RC
92 Capsule (anhydrous) 500 mg GH CHC PHC OPD RC
93 Dispersible Tablet 125 mg GH CHC PHC OPD RC
94 Tablet 500 mg + 125 mg GH CHC OPD RC
95 Injection 1gm + 200 mg GH CHC IPD RC
96 Injection 250 mg + 50 mg GH CHC IPD RC
97 Injection 500 +100 mg GH IPD RC
98 Dispersible Tablet 200 mg +28.5 mg GH CHC OPD RC
62 99 Ampicillin Injection powder (sodium) 500 mg GH CHC PHC IPD RC
100 Injection powder (penicillin) 6 lacs IU vial GH IPD RC
101 Injection powder 12 lacs IU vial GH IPD RC
102 Injection powder 24 lacs IU vial GH IPD RC
103 Tablet 100 mg GH CHC PHC OPD RC
104 Tablet 200 mg GH CHC PHC OPD RC
105 Dispersible Tablet 50 mg GH CHC PHC OPD RC
106 Tablet 250 mg GH CHC PHC Sub centre OPD RC
107 Tablet 500 mg GH CHC PHC Sub centre OPD RC
108 Syrup 125mg/ 5 ml,30ml GH CHC PHC Sub centre OPD RC
109 Drops 100 mg/ ml GH OPD RC
6.1 Antihelminthics
6.1.1 Intestinal anthelminthics
58 Albendazole
6. ANTI-INFECTIVE MEDICINES
61 Amoxicillin + clavulanic acid
63 Benzathine penicillin
6.1.2 Antifilarials
6.2 Antibacterial
6.2.1 Beta Lactam medicines
60 Amoxicillin
64 Cefixime
65 Cefadroxil
Sr. No. Medicines Dosage Forms Strength
GH CHC PHC/UD Sub centre OPD IPD OT RC LP
Category Usage
110 Injection powder 250 mg GH IPD LP
111 Injection powder 1 g vial GH IPD LP
112 Injection 250mg GH CHC PHC IPD RC
113 Injection 1 gm GH CHC PHC IPD RC
114 Injection 500 mg GH IPD RC
115 Injection powder 250 mg GH CHC PHC IPD RC
116 Injection powder 1 g vial GH CHC PHC IPD RC
117 100 mg,/2 ml GH CHC PHC IPD RC
118 500 mg/2 ml GH CHC PHC IPD RC
119 250 mg/2 ml GH CHC PHC IPD RC
120 Tablet 250 mg GH CHC PHC OPD RC
121 Tablet 500 mg GH CHC PHC OPD RC
122 Tablet 1 gm GH OPD RC
123 Suspension 200 mg/5 ml,15ml GH CHC PHC OPD RC
71 124 Levofloxacin Tablet 500 mg GH OPD RC
72 125
Ofloxacin*
To be used rationally so as to
retain its senstivity as
antitubercular agent.
Tablet 200 mg GH CHC PHC OPD RC
6.2.1 Beta Lactam Medicines(Complementary)
66 Ceftazidime (pentahydrate)
67 Cefotaxime
70 Azithromycin
68 Ceftriaxone Powder (sodium)
6.2.2 Other antibacterial
69 Amikacin Injection
Sr. No. Medicines Dosage Forms Strength
GH CHC PHC/UD Sub centre OPD IPD OT RC LP
Category Usage
126 Tablet (hydrochloride) 250 mg GH CHC PHC OPD RC
127 Tablet (hydrochloride) 500 mg GH CHC PHC OPD RC
128 Injection IV 200 mg/ 100 ml GH CHC PHC IPD RC
74 129 Ciprofloxacin +Tinidazole Tablet 500 mg + 600 mg GH CHC PHC OPD RC
75 130 Doxycycline Capsule (hydrochloride) 100 mg GH CHC PHC OPD RC
131 Tablet 500 mg GH OPD RC
132 Oral suspension powder 125 mg/5 ml,30ml GH OPD RC
77 133 Gentamycin Injection (sulphate) 40 mg/ ml, 2 ml vial GH CHC PHC IPD RC
134 Tablet 200 mg GH CHC PHC Sub centre OPD RC
135 Tablet 400 mg GH CHC PHC Sub centre OPD RC
136 Injection 500 mg/ 100ml GH CHC PHC IPD RC
137 Suspension 200 mg/50 ml GH CHC PHC OPD RC
138 Tablet 100 mg +20 mg GH CHC PHC Sub centre OPD RC
139 Tablet 800 mg + 160 mg GH CHC PHC OPD RC
140 Pessaries 200 mg GH CHC PHC Sub centre OPD RC
141 Cream 2%,30 gm GH CHC PHC OPD RC
142 Solution 1% w/v,15ml GH CHC PHC OPD RC
143 Capsule/Tablet 150 mg GH CHC PHC OPD RC
144 Capsule/Tablet 200mg GH OPD RC
145 Dispersible Tablet 50 mg GH OPD RC
82 146 Griseofulvin Tablet 250 mg GH OPD LP
147 Tablet 200 mg GH CHC PHC OPD RC
148 Tablet 400 mg GH CHC PHC OPD RC
76 Erythromycin Base
78 Metronidazole
73
Ciprofloxacin
Final selection depends on
indication for use
81 Fluconazole
6.4 Antiviral medicines(Antiherpes medicines)
83 Acyclovir
79Sulfamethoxazole +
trimethoprim (Cotrimoxazole)
6.3 Antifungal medicines
80 Clotrimazole
Sr. No. Medicines Dosage Forms Strength
GH CHC PHC/UD Sub centre OPD IPD OT RC LP
Category Usage
84 149 Tinidazole Tablet 500 mg GH CHC PHC OPD RC
85 150 Flunarazine Tablet 10 mg GH OPD RC
151 Tablet 100 mg + 10 mg GH OPD LP
152 Tablet 250 mg +25 mg GH OPD LP
87 153 Trihexyphenidyl Tablet (hydrochloride) 2 mg GH OPD RC
88 154 Bromocriptine Tablet (mesylate) 2.5 mg GH OPD LP
155 Ferrous salt Tablet Equivalent to 100 mg
elemental ironGH OPD RC
156 Ferrous salt (sulphate) Oral solution Equivalent to 25 mg
iron /mlGH OPD RC
157 Ferrous salt (Iron sucrose) Injection 20mg/ml GH IPD RC
158Ferrous salt (Iron sorbitol
citric acid complex)Injection 100 mg/ ml GH IPD RC
8. ANTIPARKINSONISM MEDICINES(Complementary)
9. MEDICINES AFFECTING THE BLOOD
9.1 Antianaemia medicines
89
6.5 Antiprotozoal medicines
7 ANTIMIGRAINE MEDICINES FOR ACUTE ATTACK
8. ANTIPARKINSONISM MEDICINES
86 Levodopa + Carbidopa
Sr. No. Medicines Dosage Forms Strength
GH CHC PHC/UD Sub centre OPD IPD OT RC LP
Category Usage
159 Tablet
Equivalent to 60 mg
iron + 400 mcg folic
acid
GH CHC PHC Sub centre OPD RC
160 Tablet Large
Equivalent to 100 mg
iron + 500 mcg folic
acid
GH CHC PHC Sub centre OPD RC
161 Tablet Medium
Equivalent to 45 mg
iron + 400 mcg folic
acid
GH CHC PHC Sub centre OPD RC
162 Tablet Small
Equivalent to 20 mg
iron + 100 mcg folic
acid
GH CHC PHC Sub centre OPD RC
163 Syrup
Equivalent to 100 mg
elemental iron + 500
mcg folic acid per 5 ml
GH CHC PHC Sub centre OPD RC
164 Drops GH OPD RC
91 165 Folic acid Tablet 5mg GH CHC PHC Sub centre OPD RC
92 166 Heparin sodium Injection 5000 IU/ ml GH IPD LP
167 Tablet 500 mg GH CHC PHC OPD RC
168 Tablet 250 mg GH CHC PHC OPD RC
169 Injection 250 mg/2 ml GH CHC PHC IPD RC
170 Tablet 2 mg GH OPD LP
171 Tablet 5 mg GH OPD LP
95 172 LMW Heparin Injection (LMW) GH IPD RC
17310 mg/ml, 1 ml
ampoule, GH CHC PHC Sub centre IPD RC
1741 mg/0.5 ml water
based single doseGH CHC PHC IPD RC
90 Ferrous sulphate + Folic acid
9.2 Medicines affecting Coagulation(Complementary)
96 Menadion Sodium Bisulphite Injection
9.2 Medicines affecting coagulation
93 Ethamsylate
94 Warfarin (sodium)
Sr. No. Medicines Dosage Forms Strength
GH CHC PHC/UD Sub centre OPD IPD OT RC LP
Category Usage
97 175Protamine sulphate (Heparin
Antagonist)Injection
10 mg/ml, 5-ml
ampouleGH IPD LP
98 176
Purified Freeze – Dried
Human Coagulation Factor
VIII, Virus inactivated
Injection 250 IU GH IPD OT RC
99 177 Plasma Volume Expander Injection 500ml GH CHC PHC Sub centre IPD RC
100 178 Atenolol Tablet 50 mg GH CHC PHC OPD RC
179 Tablet 30 mg GH OPD RC
180 Tablet 60 mg GH OPD RC
181 Injection 5 mg/ml GH IPD RC
182 Tablet (sublingual) 500 micrograms GH CHC PHC IPD RC
183 Glycerine trinitrate SR 0.5 mg GH IPD RC
184 Injection (Nitro Glycerine) 5 mg/ ml GH IPD RC
185 Tablet 5 mg GH CHC PHC IPD RC
186 Tablet 20 mg (SR) GH CHC PHC IPD RC
104 187 Isosorbide dinitrate Tablet (sublingual) 5 mg GH CHC PHC IPD RC
188 Tablet 25 mg GH CHC PHC OPD RC
189 Tablet 50 mg GH CHC PHC OPD RC
106 190 Carvediolol Tablet 3.125 mg GH OPD RC
191 Tablet 10 mg GH CHC PHC OPD LP
192 Tablet 40 mg GH CHC PHC OPD LP
108 193 Adenosine (Phosphate) Injection 3 mg/ ml GH IPD RC
109 194 Amiodarone Tablet 100 mg GH IPD LP
110 195 Digoxin Tablet 0.25 mg GH CHC OPD RC
111 196 Verapamil Tablet 40 mg GH IPD LP
102 Glycerine trinitrate
103 Isosorbide mononitrate
10. BLOOD PRODUCTS AND PLASMA SUBSTITUTES
11. CARDIOVASCULAR MEDICINES
11.1 Antianginal medicines
101 Diltiazem
11.2 Antiarrhythmic medicines
105 Metoprolol
107 Propranolol
Sr. No. Medicines Dosage Forms Strength
GH CHC PHC/UD Sub centre OPD IPD OT RC LP
Category Usage
197 Tablet 5 mg GH CHC PHC OPD RC
198 Tablet 10 mg GH CHC PHC OPD RC
113 199 Enalapril Maleate Tablet 5 mg GH CHC PHC OPD RC
114 200 Hydrochlorothiazide Tablet 25 mg GH CHC PHC OPD RC
115 201 Methyldopa Tablet 250 mg GH CHC PHC OPD RC
116 202 Losartan HCL Tablet 50 mg GH CHC PHC OPD RC
203 Capsule(Sublingual) 5 mg GH IPD LP
204 Tablet (SR) 20 mg GH OPD RC
205 Tablet 2.5 mg GH OPD RC
206 Tablet 5 mg GH OPD RC
207 Injection 20 mg GH IPD LP
208 Tablet 100 mg GH CHC OPD RC
120 209 Telmisartan HCL Tablet 40mg GH OPD RC
121 210 Dobutamine Injection 125 mg/ 5 ml GH IPD LP
122 211 Dopamine Injection (hydrochloride)40 mg/ ml in 5ml
AmpouleGH CHC IPD LP
212 Tablet 75 mg GH CHC PHC OPD RC
213 Tablet 150 mg GH CHC PHC OPD RC
124 214 Clopidogrel Tablet 75 mg GH CHC OPD RC
125 215 Streptokinase Injection powder 1500000 IU GH IPD RC
216 Tablet 10 mg GH CHC PHC OPD RC
217 Tablet 20 mg GH CHC PHC OPD RC
218 Injection 500 mg/5 ml GH CHC IPD RC
219 Tablet 500 mg GH CHC OPD RC
128 220 Mephentermine Injection 30 mg/ml GH OT RC
117 Nifedipine
118 Ramipril
11.3 Antihypertensive medicines
112 Amlodipine
123 Acetylsalicylic acid
11.6 Thrombolytic
126 Atorvastatin
119 Labetolol
Methyldopa & Labetalol is listed for use in the management of pregnancy-induced hypertension only. Its use in the treatment of essential hypertension is not
recommended in view of the availability of more evidence of efficacy and safety of other medicines.
11.4 Medicines used in heart failure
11.5 Antithrombotic medicines
11.7 Anti Fibrinolytic & Presser Agent
127 Tranexanemic Acid
Sr. No. Medicines Dosage Forms Strength
GH CHC PHC/UD Sub centre OPD IPD OT RC LP
Category Usage
129 221 Miconazole Cream (nitrate) 2%,15gm GH CHC PHC OPD RC
130 222 Clindamycin Cream 1% w/w,10gm GH OPD RC
131 223 Clobetasol + Gentamycin Ointment 0.05% + 0.1 %, 5gm GH CHC PHC OPD RC
132 224 Trichloroacetic Acid Crystal GH OT LP
133 225 Permethrin (Only for scabies) Cream 5%, 30 gm GH CHC PHC OPD RC
134 226 Acyclovir Cream 5% GH OPD RC
227 Aqueous solution 1 : 10 000 GH CHC PHC IPD LP
228 Crystal 100 gm GH CHC PHC IPD LP
136 229 Silver sulfadiazine Cream 1%,250mg GH CHC PHC Sub centre OPD RC
137 230 Betamethasone Cream (Dipropionate) 0.1% GH CHC PHC OPD RC
138 231 Calamine lotion Lotion 8% GH CHC OPD RC
139 232 Fluticasone Ointment 0.005% GH OPD RC
140 233 Momaetasone Furoate Lotion 0.1%, 15 ml GH OPD RC
141 234 Fluocinolone Acetonide Ointment 0.1% GH OPD RC
142 235 Benzoyl Per Oxide Gel 2.5%, 10 gm GH OPD RC
236 Lotion 1%, 100 ml GH CHC PHC Sub centre OPD RC
237 Cream 1%, 25 gm GH CHC PHC Sub centre OPD RC
144 238 Hydrogen Peroxide Solution 1% GH CHC PHC OT RC
145 239 Cetrimide Solution 20% conc. for dilution GH CHC PHC OT RC
12.1 Antifungal medicines
12.1 Skin(Complementary)
12.2 Anti-infective medicines
135 Potassium permanganate
12. DERMATOLOGICAL MEDICINES (topical)
13. DISINFECTANTS AND ANTISEPTICS
13.1 Antiseptics
12.3 Anti-inflammatory and antipruritic medicines
12.4 Medicines affecting skin differentiation and proliferation
12.5 Scabicides and pediculicides
143Gamma Benzene
Hexachloride
Sr. No. Medicines Dosage Forms Strength
GH CHC PHC/UD Sub centre OPD IPD OT RC LP
Category Usage
146 240 Chlorhexidine Solution 5% conc. for dilution GH CHC PHC Sub centre OT RC
241 Solution 5%,500ml, GH CHC PHC Sub centre OT RC
242 Solution 10%, 500 ml GH OT RC
243 Solution 5%,5 litre GH CHC PHC OT RC
244 Ointment 5%,15gm GH CHC PHC Sub centre IPD RC
245 Ointment 5%,250 gm GH CHC PHC Sub centre OPD RC
246 Scrub 7.5%, 500 ml GH CHC PHC Sub centre IPD RC
247 Cream 1%, 100 gm GH IPD RC
248 Cream 1 % 20gm GH CHC PHC OPD RC
149 249 Bleaching powder Powder GH CHC PHC Sub centre OT RC
150 250 Glutraldehyde Solution 2% / 2.4% GH CHC IPD RC
251 Tablet 40 mg GH CHC PHC OPD RC
252 Injection10 mg/ml 2-ml
ampouleGH CHC PHC IPD RC
152 253 Mannitol Injectable solution 20%, 350 ml GH CHC IPD RC
153 254 Spironolactone Tablet 25 mg GH OPD RC
154 255 Tamsulosin Hydrochloride Tablet 0.4 mg GH CHC OPD RC
155 256 Tamsulosin + Dutasteride Tablet 0.4 mg + 0.5 mg GH OPD RC
156 257 Flavoxate Hydrochloride Tablet 200 mg GH CHC OPD RC
157 258 Disodium Hydrogen Citrate Suspension 1.38 gm/100 ml GH CHC PHC OPD RC
158 259 Sodium Bicarbonate Injection 7.5% GH CHC PHC IPD LP
13.1 Antiseptics(Complementary)
148 Framycetin
13.2 Disinfectants
147 Povidone iodine
14.2 Medicines for BPH
14.3 Alkalising Solution
14.3 Alkalising(Complementary)
14. MEDICINES FOR UROLOGY
14.1 Diuretics
151 Furosemide
Sr. No. Medicines Dosage Forms Strength
GH CHC PHC/UD Sub centre OPD IPD OT RC LP
Category Usage
260 Chewable Tablet 250 mg +250 mg + 25
mgGH CHC PHC OPD RC
261 Oral suspension300 mg+ 150 mg+ 40
mg/ 5 ml, 180 mlGH CHC PHC OPD RC
160 262
Aluminium hydroxide +
magnesium hydroxide +
Simethicone + magnesium
Carbonate
Chewable Tablet 240 mg+100 mg+25
mg +60 mg GH CHC PHC OPD RC
161 263 Omeprazole Capsule 20 mg GH CHC PHC OPD RC
264 Tablet (HCL) 150 mg GH CHC PHC Sub centre OPD RC
265 Injection 25 mg/ml in 2-ml amp GH CHC PHC IPD RC
266 Tablet 10 mg GH CHC PHC Sub centre OPD RC
267 Suspension 1 mg/ ml, 30ml GH CHC PHC Sub centre OPD RC
164 268 Cinnarizine Tablet 25 mg GH CHC PHC OPD RC
269 Tablet (Hydrochloride) 10 mg GH CHC PHC OPD RC
270 Injection (hydrochloride) 5 mg/ ml in 2-ml amp GH CHC PHC IPD RC
271 Tablet 5 mg GH CHC PHC OPD RC
272 Injection 12.5 mg/ml GH IPD RC
15. GASTROINTESTINAL MEDICINES
15.1 Antacids and other antiulcer medicines
159
Aluminium hydroxide +
magnesium hydroxide +
Simethicone
165 Metoclopramide
166 Prochlorperazine
162 Ranitidine
15.2 Antiemetic medicines
163 Domperidone
Sr. No. Medicines Dosage Forms Strength
GH CHC PHC/UD Sub centre OPD IPD OT RC LP
Category Usage
273 Tablet 4 mg GH CHC PHC IPD RC
274 Tablet 8 mg GH CHC PHC IPD RC
275 Injection 2 mg/ ml 2ml ampoule GH CHC PHC IPD RC
276 Tablet (hydrochloride) 25 mg GH CHC PHC OPD RC
277 Elixir or syrup (hcl) 5 mg/ 5 ml GH CHC PHC OPD RC
278 Injection (hydrochloride) 25 mg/ml in 2-ml amp GH CHC PHC IPD RC
169 279 Doxylamine succinate Tablet 10 mg GH CHC OPD RC
170 280
Local anaesthetic, astringent
and anti-inflammatory
medicines
Ointment or suppository GH CHC PHC OPD RC
171 281 Dicyclomine Tablet (hydrochloride) 10 mg GH CHC PHC Sub centre OPD RC
172 282Mephenamic Acid +
DicyclomineTablet 500 mg +20 mg GH CHC PHC OPD RC
283 Tablet 80 mg GH CHC PHC OPD RC
284 Injection 40 mg/ 2 ml GH CHC PHC IPD RC
285 Tablet 10 mg GH CHC PHC OPD RC
286 Injection 20 mg/ ml GH CHC PHC IPD RC
175 287 Bisacodyl Tablet 5 mg GH CHC PHC OPD RC
176 288 Milk of Magnesia +Liquid
ParaffinSuspension
11.25 ml + 3.75 ml/ 15
ml (50 ml Packing)GH CHC PHC OPD RC
177 289 Glycerine Saline Enema GH CHC IPD LP
290 Powder for solution As per IP GH CHC PHC Sub centre OPD RC
291 Powder for solution For 200 ml GH CHC PHC Sub centre OPD RC
292 Tablet (Sulphate) 20 mg GH CHC PHC Sub centre OPD RC
293 Suspension (Sulphate) 20 mg/5 ml GH CHC PHC Sub centre OPD RC
174 Hyoscine butyl bromide
15.5 Laxatives
15.3 Antihaemorrhoidal medicines
15.4 Antispasmodic medicines
173 Drotaverine
167 Ondansetron
168 Promethazine
179 Zinc
15.6 Medicines used in Diarrhoea
178 Oral rehydration salts
Sr. No. Medicines Dosage Forms Strength
GH CHC PHC/UD Sub centre OPD IPD OT RC LP
Category Usage
180 294 Glibenclamide Tablet 5 mg GH CHC PHC OPD RC
181 295 Glimipride Tablet 1 mg GH CHC OPD RC
296 Tablet 40 mg GH CHC OPD RC
297 Tablet 80 mg GH CHC OPD RC
183 298Biphasic Isophane (R-DNA
origin 30/70Injection 40 I.U/ml GH IPD RC
184 299 Insulin (soluble) Injection 40 IU/ml in 10 ml vial GH IPD RC
185 300 Intermediate-acting insulin
(Lente)Injection 40 IU/ml in 10 ml vial GH IPD RC
301 Tablet (hydrochloride) 500 mg GH CHC PHC OPD RC
302 Tablet (hydrochloride) 1 gm SR GH OPD RC
187 303 Clomifene Tablet (citrate) 50 mg GH OPD RC
188 304 Medroxyprogesterone acetate Tablet 10mg GH OPD RC
189 305 Progesterone Tablet 100 mg GH OPD RC
190 306 Norethisterone Tablet 5 mg GH OPD RC
191 307 Levothyroxine Tablet (sodium) 50 mcg GH CHC PHC OPD RC
192 308 Carbimazole Tablet 5 mg GH OPD RC
193 309 Propylthiouracil Tablet 50 mg GH OPD LP
194 310Tuberculin, purified protein
derivative (PPD)Injection 2 T.U./0.1 ml GH IPD RC
16.1 Insulins and other antidiabetic
182 * Gliclazide
16. HORMONES
17.1 Diagnostic agents
All tuberculins should comply with the WHO Requirements
16.3 Progestogens
16.4 Thyroid hormones and antithyroid medicines
17. IMMUNOLOGICALS
186 Metformin
16.2 Ovulation inducers
Sr. No. Medicines Dosage Forms Strength
GH CHC PHC/UD Sub centre OPD IPD OT RC LP
Category Usage
311 Injection 50 mcg / vial GH CHC PHC IPD RC
312 Injection 150 mcg/vial GH IPD RC
313 Injection 300mcg/vial GH CHC PHC IPD RC
196 314 Anti Rabies Immunoglobulin Injection 3000 IU /ml GH IPD LP
197 315 Tetanus vaccine Injection 0.5 ml Ampoule GH CHC PHC Sub centre IPD RC
198 316 Hepatitis B vaccine Injection1 % vial, 10 mg/ml, 10
ml vialGH CHC PHC Sub centre IPD RC
317 Injection ID 1 ml GH CHC PHC IPD RC
318 Injection IM 0.5 ml GH CHC PHC IPD RC
200 319 Atracurium besylate Injection 10 mg/ ml GH OT RC
201 320 Succinyl Choline Vial Injection 50 mg/ml GH OT RC
202 321 Neostigmine (methyl) Injection 500 mcg/ ml in 1 ml
amp GH OT RC
203 322Vecuronium (bromide powder
)Injection
4 mg Dry Powder/
AmpouleGH OT LP
204 323 Recronium Bromide Injection 10 mg/ ml GH OT LP
205 324 Chloramphenicol Ointment 1% GH CHC PHC Sub centre OPD RC
325 Drops 0.3% GH CHC PHC Sub centre OPD RC
326 Ointment 0.3% GH OPD RC
207 327Ciprofloxacin +
Dexamethasone Eye Drops 0.3% +0.1% GH OPD RC
208 328 Acylovir Eye Oint 5%, 5 gm GH OPD LP
209 329 Tobramycin Eye drops 0.3%w/v, 5 ml GH OPD RC
17.2 Sera and immunoglobulins
18. MUSCLE RELAXANTS (PERIPHERALLY ACTING) AND CHOLINESTERASE INHIBITORS
19. OPHTHALMOLOGICAL PREPARATIONS
19.1 Anti-infective agents
17.3 For specific groups of individuals
199
Anti Rabies vaccine (Chick-
Embryo/Verocell/Human
Diploid)
All plasma fractions should comply with the WHO Requirements for the Collection, Processing and Quality Control of Blood, Blood Components and
Plasma Derivatives.
195
Anti-RHO-D
Immunoglobulin(Human)
Injection (Polyclonal)
(Thiomersal Free)
206 Ciprofloxacin
Sr. No. Medicines Dosage Forms Strength
GH CHC PHC/UD Sub centre OPD IPD OT RC LP
Category Usage
210 330 Moxifloxacin Eye drops 0.5%w/v, 5 ml GH OPD RC
211 331 Natamycin Eye Drops 2% GH OPD LP
212 332 Prednisolone (sodium
phosphate)Eye drops 1% GH OPD RC
213 333 Flurbiprofen Eye Drop 0.03% GH OPD RC
214 334 Flouromethalone Eye drops 0.1% w/v GH OPD RC
19.4 Miscellaneous
215 335 Hyaluronidase Injection 1500 IU/ ml GH OT LP
216 336 Tryphen Blue Dye GH OT LP
217 337 Acetazolamide Tablet 250 mg GH OPD RC
218 338 Pilocarpine (hydrochloride or
nitrate)Eye drops 2% GH OPD RC
339 Eye drops 0.25% , 5 ml GH OPD RC
340 Eye drops 0.5%, 5 ml GH OPD RC
341 Drops 1% GH IPD LP
342 Ointment 1% GH IPD LP
221 343 Cyclopentolate Eye Drop 1% w/w GH IPD RC
222 344 Homatropine Eye Drops 1% GH IPD LP
223 345 Tropicamide +
Phenylepherine Eye Drops 0.8% + 5% GH IPD RC
224 346 Hydroxypropyl mehtylcellulose Injection 2% GH IPD RC
225 347 Sodium Carboxymethyl
Cellulose Eye Drops 0.5% w/v GH OPD RC
226 348 Anti Allergic Eye Drops GH CHC PHC OPD RC
227 349 Disodium Cromoglycate Eye Drops GH CHC PHC OPD RC
19.6 Mydriatics
220 Atropine (sulphate)
19.5 Miotics and antiglaucoma medicines
219 Timolol (maleate)
19.2 Anti Fungal
19.3 Anti-inflammatory agents
19.7 Lubricating
19.8 Anti Allergic
20. NASAL ENT
Sr. No. Medicines Dosage Forms Strength
GH CHC PHC/UD Sub centre OPD IPD OT RC LP
Category Usage
350 Drops 0.05%, GH CHC PHC OPD RC
351 Drops 0.1% GH CHC PHC OPD RC
229 352 Saline Nasal Drops 0.6% GH CHC PHC Sub centre OPD RC
230 353 Glycerin Solution 500 gm bottle GH CHC PHC OPD RC
231 354
Paradichlorbenzene +
Benzocain + Chlorbutol +
Turpentine Oil
Ear Drops2 % + 2.7 % + 5 % +
15 %GH CHC PHC OPD RC
232 355
Chloremphenicol
+Beclomethasone
dipropoinate +Clotrimazole +
lignocaine Hydrochloride HCL
Ear Drops5 % w/v + 0.025% w/v
+ 1 % w/v + 2 % w/v GH CHC PHC OPD RC
233 356 Clotrimazole Ear Drops GH CHC PHC OPD RC
357 Tablet 125 mcg GH CHC PHC Sub centre OPD RC
358 Injection200 mcg in 1 ml
ampouleGH CHC PHC Sub centre IPD RC
235 359 Oxytocin Injection 5 IU in 1 ml ampoule GH CHC PHC Sub centre IPD RC
236 360 Carboprost Injection 25 mg/ml(250 mcg) GH IPD RC
237 361 Dinoprostone Gel 0.5 mg, 3 gm GH IPD RC
238 362 Mifepristone Tablet 200 mg GH CHC OPD RC
363 Tablet 25 mcg GH IPD RC
364 Tablet 200 mcg GH CHC PHC Sub centre IPD RC
365 Tablet 10 mg GH CHC PHC OPD RC
366 Injection 5 mg/ ml GH CHC PHC IPD RC
241 367 Valethemate Injection 8mg/ml GH CHC PHC IPD RC
242 368Chlorpromazine
(hydrochloride) Tablet 50 mg GH OPD RC
243 369 Fluphenazine (Decanoate) Injection 25 mg, 1 ml ampoule GH IPD RC
370 Tablet 5 mg GH OPD RC
21.1 Oxytocics
234 Methyl ergometrine
228 Xylometazoline
21. OXYTOCICS AND ANTIOXYTOCICS
22. PSYCHOTHERAPEUTIC MEDICINES
22.1 Medicines used in psychotic disorders
244 Haloperidol
21.2 Antioxytocics
240 Isoxsuprine (hydrochloride)
21.1 Oxytocics (Complementary)
239 Misoprostol
Sr. No. Medicines Dosage Forms Strength
GH CHC PHC/UD Sub centre OPD IPD OT RC LP
Category Usage
371 Injection 5 mg , 1 ml ampoule GH IPD RC
245 372 Risperidone Tablet 2gm GH OPD RC
246 373 Quetiapine Tablet SR 50 mg GH OPD RC
247 374 Amitriptyline (hydrochloride) Tablet 10 mg GH CHC OPD RC
248 375 Fluoxetine (hydrochloride) Capsule 20 mg GH CHC PHC OPD RC
249 376 Sertraline Tablet (SR) 50 mg GH OPD RC
250 377 Lithium carbonate Tablet 300 mg GH OPD RC
378 Tablet 0.25 mg GH CHC PHC OPD RC
379 Tablet 0.5 mg GH CHC PHC OPD RC
252 380 Donepezil Tablet 5 mg GH OPD RC
253 381 Clonazepam Tablet 0.5mg GH OPD RC
254 382 Bupropion Tablet 150mg GH OPD RC
255 383 Buprenorphine Tablet (Sublingual) 0.4mg GH OPD RC
256 384 Aminophylline Injection25 mg/ ml, 10 ml
ampouleGH CHC IPD LP
257 385 Ipratropium bromide –
aerosolNebulizing Solution GH IPD LP
258 386
Cough Expectorent
(Salbutamol 2 mg +
Bromhexine 4 mg)
SyrupSalbutamol 2 mg +
Bromhexine 4 mg GH CHC PHC OPD RC
387 Inhalation – aerosol 100 micrograms/ dose GH CHC PHC OPD RC
388 Suspension 2 mg/5 ml GH CHC PHC OPD RC
389Nebulizer solution
(sulphate)5 mg/ ml GH CHC PHC IPD RC
260 390Beclomethasone +
SalbutamolInhalation (MDI) GH OPD RC
244 Haloperidol
23. MEDICINES ACTING ON THE RESPIRATORY TRACT
23.1 Antiasthmatic and medicines for chronic obstructive pulmonary disease
259 Salbutamol
251 Alprazolam
22.5 Medicines used for Deaddiction
22.2 Medicines used in depressive disorders
22.3 Medicines used in bipolar disorders
22.4 Medicines used in generalized anxiety and sleep disorders
Sr. No. Medicines Dosage Forms Strength
GH CHC PHC/UD Sub centre OPD IPD OT RC LP
Category Usage
391 Tablet 115 mg + 35 mg, GH CHC PHC OPD RC
392 Tablet 231 mg + 69 mg GH CHC PHC OPD RC
393 Injection169.4 mg + 56.6 mg/2
mlGH CHC PHC IPD RC
262 394 Budesonide Nebulizer solution 15 ml vial GH CHC IPD RC
395 Tablet (sulphate) 2 mg GH CHC PHC OPD RC
396 Tablet (sulphate) 4 mg GH CHC PHC OPD RC
397 Injectable solution 5%, isotonic GH CHC PHC Sub centre IPD RC
398 Injectable solution 10% isotonic GH IPD RC
399 Injectable 25% GH IPD RC
265 400 Glucose with sodium
chloride/salineInjectable solution
5% glucose + 0.9%
sodium chlorideGH CHC PHC IPD RC
266 401 Isolyte – P Injection GH CHC PHC IPD RC
267 402 Potassium chloride Injectable solution 11.2% in 20ml GH IPD RC
268 403 Ringer lactate Injectable IV solution GH CHC PHC Sub centre IPD RC
269 404 Sodium bicarbonate Injectable IV solution 7.5% GH CHC PHC IPD RC
270 405 Sodium chloride Injectable solution 0.9% isotonic GH CHC PHC IPD RC
271 406 Water for injection Injection 5ml ampoule GH CHC PHC IPD RC
272 407 Ascorbic acid Tablet 500 mg GH CHC PHC OPD RC
408 Tablet 500 mg GH CHC PHC Sub centre OPD RC
409 Syrup GH OPD RC
274 410 Pyridoxine HCl Tablet 10 mg GH OPD RC
275 411 Vitamin A Suspension 100000 IU/ml GH CHC PHC Sub centre OPD RC
412 Syrup GH CHC PHC OPD RC
413 Injection GH CHC PHC IPD RC
414 Drops GH CHC PHC OPD RC
277 415 B-Complex Tablet GH CHC PHC Sub centre OPD RC
276 Multi Vitamin
24.2 Miscellaneous
25. VITAMINS AND MINERALS
273 Calcium salts
24. SOLUTIONS CORRECTING WATER, ELECTROLYTE AND ACID-BASE DISTURBANCES
24.1 Parenteral
264 Glucose/dextrose
261 Etophylline + Theophylline
263 Salbutamol
Sr. No. Medicines Dosage Forms Strength
GH CHC PHC/UD Sub centre OPD IPD OT RC LP
Category Usage
416 Cholecalciferol sachets 1000 IU GH CHC PHC OPD RC
417 Drops 4000IU GH CHC PHC OPD RC
418 Tablet (Chewable) 60000 IU GH CHC PHC OPD RC
419 Tablet 50 mg GH CHC PHC OPD RC
420 Injection 60 mg/ml GH CHC IPD RC
280 421 Artemether Injection 80 mg/ml, 1 ml amp GH CHC IPD RC
422 Tablet 150 mg base GH CHC PHC Sub Centre OPD RC
423 Suspension 50 mg/ 5 ml GH CHC OPD RC
424 Tablet 2.5 mg GH CHC PHC OPD RC
425 Tablet 7.5 mg GH CHC PHC OPD RC
426 Tablet 15 mg GH CHC PHC OPD RC
283 427 Quinine (Dihydrochloride) Injection300 mg/ ml, 2ml
ampouleGH CHC IPD RC
284 428 Sulfadoxine + Pyrimethamine Tablet 500 mg + 25 mg GH CHC PHC OPD RC
281 Chloroquine (Phosphate)
282 Primaquine (Diphosphate)
26. ANTIMALARIAL MEDICINES (TO BE PROCURED AT STATE LEVEL)
279 Artesunate
278 Vitamin D